Nextplat Corp (NXPL) - Total Liabilities

Latest as of September 2025: $8.47 Million USD

Based on the latest financial reports, Nextplat Corp (NXPL) has total liabilities worth $8.47 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Nextplat Corp to assess how effectively this company generates cash.

Nextplat Corp - Total Liabilities Trend (2002–2024)

This chart illustrates how Nextplat Corp's total liabilities have evolved over time, based on quarterly financial data. Check Nextplat Corp asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Nextplat Corp Competitors by Total Liabilities

The table below lists competitors of Nextplat Corp ranked by their total liabilities.

Company Country Total Liabilities
Hanan Mor
TA:HNMR
Israel ILA2.84 Billion
Texmo Pipes and Products Limited
NSE:TEXMOPIPES
India Rs1.37 Billion
Bergen Carbon Solutions A/S
OL:BCS
Norway Nkr17.54 Million
TAG Oil Ltd.
V:TAO
Canada CA$2.43 Million
BIGG Digital Assets Inc
F:7111
Germany €200.43 Million
Audalia Resources Ltd
AU:ACP
Australia AU$11.94 Million
Banco Santander Río S.A
BA:BRIO6
Argentina AR$19.89 Trillion
DOTZ Nano Ltd
AU:DTZ
Australia AU$5.07 Million

Liability Composition Analysis (2002–2024)

This chart breaks down Nextplat Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Nextplat Corp stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.56 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.40 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.28 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nextplat Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nextplat Corp (2002–2024)

The table below shows the annual total liabilities of Nextplat Corp from 2002 to 2024.

Year Total Liabilities Change
2024-12-31 $9.68 Million -40.91%
2023-12-31 $16.38 Million +471.20%
2022-12-31 $2.87 Million -5.49%
2021-12-31 $3.03 Million -25.98%
2020-12-31 $4.10 Million +49.06%
2019-12-31 $2.75 Million +160.39%
2018-12-31 $1.06 Million -12.23%
2017-12-31 $1.20 Million +67.01%
2016-12-31 $720.62K -49.76%
2015-12-31 $1.43 Million +105.78%
2014-12-31 $696.96K -8.99%
2013-12-31 $765.83K -55.35%
2012-12-31 $1.72 Million +149.04%
2011-12-31 $688.76K -90.69%
2010-12-31 $7.40 Million +2950.88%
2009-12-31 $242.45K -54.87%
2008-12-31 $537.29K +65.14%
2006-12-31 $325.36K +9.31%
2005-12-31 $297.65K +674.12%
2004-12-31 $38.45K +13.27%
2003-12-31 $33.95K -13.03%
2002-12-31 $39.03K --

About Nextplat Corp

NASDAQ:NXPL USA Software - Application
Market Cap
$166.77 Million
Market Cap Rank
#25897 Global
#5200 in USA
Share Price
$6.34
Change (1 day)
-0.78%
52-Week Range
$0.37 - $6.93
All Time High
$3937.50
About

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. It operates through two segments, e-Commerce Operations and Healthcare Operations. The company operates full-service retail and specialty services pharmacies that provide prescription pharmaceuticals, third-party administration, risk and data management, compoun… Read more